X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (18) 18
netherlands (16) 16
health care sciences & services (13) 13
health policy & services (11) 11
oncology (10) 10
internal medicine (9) 9
health policy (8) 8
care and treatment (7) 7
decision making (7) 7
economics (7) 7
cost-benefit analysis (6) 6
drugs (6) 6
health administration (6) 6
male (6) 6
middle aged (6) 6
aged (5) 5
analysis (5) 5
antineoplastic agents - therapeutic use (5) 5
bortezomib (5) 5
cancer (5) 5
decision-making (5) 5
female (5) 5
melanoma (5) 5
pharmacology & pharmacy (5) 5
policy making (5) 5
adult (4) 4
antineoplastic agents - economics (4) 4
cost-effectiveness (4) 4
drug costs (4) 4
drug reimbursement (4) 4
health-care (4) 4
hematology (4) 4
insurance, health, reimbursement - economics (4) 4
ipilimumab (4) 4
metastatic melanoma (4) 4
outcomes research (4) 4
public health, environmental and occupational health (4) 4
registries (4) 4
survival (4) 4
treatment outcome (4) 4
antiquities (3) 3
clinical trials (3) 3
dexamethasone (3) 3
dosage and administration (3) 3
economic aspects (3) 3
europe (3) 3
excavations (3) 3
france (3) 3
health care (3) 3
health economics (3) 3
health technology assessment (3) 3
hematology, oncology and palliative medicine (3) 3
insurance, pharmaceutical services - economics (3) 3
internationality (3) 3
medical oncology - economics (3) 3
melanoma - drug therapy (3) 3
multiple myeloma - drug therapy (3) 3
multiple-myeloma (3) 3
open-label (3) 3
pharmaceuticals (3) 3
policy (3) 3
quality-adjusted life years (3) 3
reimbursement (3) 3
reimbursement mechanisms (3) 3
research (3) 3
safety (3) 3
skin neoplasms - drug therapy (3) 3
sweden (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
antiquités (2) 2
belgium (2) 2
bortezomib - therapeutic use (2) 2
clinical practice (2) 2
comparative analysis (2) 2
cost analysis (2) 2
coverage (2) 2
criteria (2) 2
dacarbazine (2) 2
design (2) 2
diagnosis (2) 2
drug therapy (2) 2
efficacy (2) 2
evidence development (2) 2
feasibility (2) 2
feasibility studies (2) 2
follow-up (2) 2
fouilles (2) 2
guidelines as topic (2) 2
health policy - economics (2) 2
health technology-assessment (2) 2
healthcare costs (2) 2
immune-related adverse events (2) 2
insurance, health, reimbursement - statistics & numerical data (2) 2
insurance, pharmaceutical services - statistics & numerical data (2) 2
ipilimumab - therapeutic use (2) 2
jerusalem antiquities (2) 2
management (2) 2
medical care, cost of (2) 2
medical economics (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (3) 3
UTL at Downsview - May be requested (2) 2
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Royal Ontario Museum - Archives (1) 1
Royal Ontario Museum - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Value in Health, ISSN 1098-3015, 2016, Volume 20, Issue 4, pp. 627 - 636
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 72, pp. 156 - 165
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2017, Volume 35, Issue 25, pp. 2976 - 2977
Journal Article
Journal Article
Haematologica, ISSN 0390-6078, 05/2019, Volume 104, Issue 5, pp. 1026 - 1035
Decision making for patients with multiple myeloma (MM) not transplant eligible (NTE) is complicated by a lack of head-to-head comparisons of standards of... 
DEXAMETHASONE | INCONSISTENCY | LENALIDOMIDE | TERM-FOLLOW-UP | INITIAL TREATMENT | RANDOMIZED-TRIAL | PREDNISONE PLUS THALIDOMIDE | BORTEZOMIB | HEMATOLOGY | ELDERLY-PATIENTS | MELPHALAN
Journal Article
Health Policy, ISSN 0168-8510, 2013, Volume 112, Issue 1-2, pp. 28 - 34
Journal Article
Journal Article